| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $46.7M | +244.6% |
| Cost of Revenue | $18.1M | +234.9% |
| R&D Expense | $5.0M | +86.3% |
| SG&A Expense | $65.9M | +1317.6% |
| Operating Income | -$77.7M | -573.4% |
| Pre-tax Income | -$99.9M | -601.3% |
| Income Tax | -$24K | +44.0% |
| Net Income | -$99.7M | -610.7% |
| EPS (Basic) | -$2.26 |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.2M | +1798.1% |
| Accounts Receivable | $3.7M | +137.8% |
| Inventory | $71K | +18.0% |
| Current Assets | $49.8M | — |
| Total Assets | $58.1M | -72.3% |
| Current Liabilities | $65.7M | +1718.9% |
| Long-term Debt | $1.5M | +125.5% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.4M | -104.4% |
| Investing Cash Flow | -$6.7M | -696.9% |
| Financing Cash Flow | $21.6M | +158.0% |
| -162.8% |
| EPS (Diluted) | -$2.26 | -162.8% |
| Total Liabilities |
| $68.6M |
| +577.3% |
| Stockholders' Equity | -$10.1M | -2.1% |